The Potential of Pharmacogenomics to Advance Kidney Disease Treatment.
作者信息
Birdwell Kelly A, Chung Cecilia P
机构信息
Division of Nephrology, Department of Medicine and.
Division of Rheumatology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
出版信息
Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1035-1037. doi: 10.2215/CJN.05170517. Epub 2017 Jun 19.
Abstract
摘要
相似文献
1
The Potential of Pharmacogenomics to Advance Kidney Disease Treatment.药物基因组学推动肾脏疾病治疗的潜力。
Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1035-1037. doi: 10.2215/CJN.05170517. Epub 2017 Jun 19.
2
Clinical Pharmacogenomics: Applications in Nephrology.临床药物基因组学：在肾脏病学中的应用。
Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1561-1571. doi: 10.2215/CJN.02730218. Epub 2018 May 23.
3
No pain relief from codeine...? An introduction to pharmacogenomics.
Acta Anaesthesiol Scand. 2001 Feb;45(2):140-9.
4
Role of pharmacogenomics in dialysis and transplantation.药物基因组学在透析和移植中的作用。
Curr Opin Nephrol Hypertens. 2014 Nov;23(6):570-7. doi: 10.1097/MNH.0000000000000065.
5
Pharmacogenetics and pharmacogenomics: development, science, and translation.药物遗传学与药物基因组学：发展、科学与转化
Annu Rev Genomics Hum Genet. 2006;7:223-45. doi: 10.1146/annurev.genom.6.080604.162315.
6
Pharmacogenomics in Cardiovascular Diseases.心血管疾病的药物基因组学。
Curr Protoc. 2021 Jul;1(7):e189. doi: 10.1002/cpz1.189.
7
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?药物遗传学和药物基因组学：为何这与临床遗传学家相关？
Clin Genet. 1999 Oct;56(4):247-58. doi: 10.1034/j.1399-0004.1999.560401.x.
8
Pharmacogenomics and schizophrenia.
Eur J Pharmacol. 2000 Dec 27;410(2-3):227-241. doi: 10.1016/s0014-2999(00)00817-7.
9
Asymmetry in scientific method and limits to cross-disciplinary dialogue: toward a shared language and science policy in pharmacogenomics and human disease genetics.科学方法中的不对称性与跨学科对话的局限性：迈向药物基因组学和人类疾病遗传学中的共享语言与科学政策
J Investig Med. 2007 Apr;55(3):130-41. doi: 10.2310/6650.2007.06042.
10
Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications.药物遗传学和药物基因组学中的临床试验：方法与应用
Am J Health Syst Pharm. 2000 May 1;57(9):887-98; quiz 899-901. doi: 10.1093/ajhp/57.9.887.
引用本文的文献
1
Pharmacogenetics of immunosuppressant drugs: A new aspect for individualized therapy.免疫抑制剂药物的药物遗传学：个体化治疗的新方向。
World J Transplant. 2020 May 29;10(5):90-103. doi: 10.5500/wjt.v10.i5.90.
2
Kidney podocyte-associated gene polymorphisms affect tacrolimus concentration in pediatric patients with refractory nephrotic syndrome.肾足细胞相关基因多态性影响难治性肾病综合征患儿的他克莫司血药浓度。
Pharmacogenomics J. 2020 Aug;20(4):543-552. doi: 10.1038/s41397-019-0141-x. Epub 2020 Jan 6.
Zotero 插件